Euclidean Capital LLC: ISHARES MSCI IND (INDA): Quarterly 13F Position History
As of Q1 2026, Euclidean Capital LLC reported 369,600 shares of ISHARES MSCI IND (INDA), worth $17.3M and representing 4.4% of its 13F equity book. The position first appeared in Q4 2022 and has been disclosed across 14 13F-HR filings in Pactolio's tracked window.
- 369,600Shares Held (Latest Filing)
- $17.3MReported Market Value (Latest Filing)
- 4.4%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$2.7MQuarter-over-Quarter Value Change
- 2,425,144Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 14 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 369,600 | 0 | — | $17.3M | 4.4% | $46.8 |
| Q4 2025 | 369,600 | 0 | — | $20.0M | 5.4% | $54.0 |
| Q3 2025 | 369,600 | 2,055,544 | -84.8% | $19.2M | 8.1% | $52.1 |
| Q2 2025 | 2,425,144 | 0 | — | $135.0M | 44.2% | $55.7 |
| Q1 2025 | 2,425,144 | 0 | — | $124.8M | 46.9% | $51.5 |
| Q4 2024 | 2,425,144 | 0 | — | $127.7M | 17.3% | $52.6 |
| Q3 2024 | 2,425,144 | 0 | — | $141.9M | 15.7% | $58.5 |
| Q2 2024 | 2,425,144 | 0 | — | $135.3M | 17.0% | $55.8 |
| Q1 2024 | 2,425,144 | 0 | — | $125.1M | 16.0% | $51.6 |
| Q4 2023 | 2,425,144 | 0 | — | $118.4M | 13.3% | $48.8 |
| Q3 2023 | 2,425,144 | 0 | — | $107.2M | 23.4% | $44.2 |
| Q2 2023 | 2,425,144 | +1,225,000 | +102.1% | $106.0M | 27.2% | $43.7 |
| Q1 2023 | 1,200,144 | +623,000 | +107.9% | $47.2M | 41.4% | $39.4 |
| Q4 2022 | 577,144 | — | — | $24.1M | 22.5% | $41.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Euclidean Capital LLC first disclose a INDA position in 13F-HR filings?
Euclidean Capital LLC first reported ISHARES MSCI IND (INDA) on its 13F-HR filing for the period ending 2022-12-31 (Q4 2022). The position has appeared on 14 reported quarters within Pactolio's tracked window.
What was Euclidean Capital LLC's most recent quarter-over-quarter share-count change in INDA?
Euclidean Capital LLC held the same 369,600 shares of INDA between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Euclidean Capital LLC's cost basis in INDA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.